SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001714899-23-000101
Filing Date
2023-06-05
Accepted
2023-06-05 18:08:30
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686002897.html 4  
1 FORM 4 wk-form4_1686002897.xml 4 5838
  Complete submission text file 0001714899-23-000101.txt   7237
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036
Business Address
Thornberry Nancy (Reporting) CIK: 0001797826 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 23994207